 |
IDF
establishes Diabetes Trust Fund for Haiti |
| |
IDF is setting up a Haiti Diabetes Trust Fund
where member associations can support people with diabetes during
the emergency and contribute to rebuilding services for the more
than 300,000 people with diabetes in Haiti in the longer term (IDF) |
| |
|
|
D-Start
(Diabetes, Supporting TrAnslational Research and Twinning) |
| |
On January 15 2010, the International Diabetes
Federation launched D-START (Diabetes, Supporting TrAnslational
Research and Twinning), an initiative that aims to support the
development of innovative projects in low and middle- income countries
(LMCs - BRIDGES / IDF) |
| |
|
|
BRIDGES
(Bringing Research in Diabetes to Global Environments and Systems) |
| |
BRIDGES aims to fund translational research
projects in diabetes prevention and treatment to provide the opportunity
to ‘translate’ lessons learned from clinical research to those
who can benefit most: people affected by diabetes (BRIDGES / IDF) |
| |
|
|
Changes
in the Position of Conventional Insulin Pumps Shown to Significantly
Impact Accuracy of Insulin Delivery |
| |
Researchers at Sansum Diabetes Research Institute
and University of California, Santa Barbara have concluded that
changing the height of a conventional insulin pump in relation
to its tubing and infusion set can significantly impact expected
insulin delivery rates. Such changes can occur during routine daily
activities like dressing, sleeping or showering (CNN) |
| |
|
|
JDRF
and BD Collaborate to Improve Insulin Pump Delivery |
| |
The Juvenile Diabetes Research Foundation and
Becton, Dickinson announce an innovative program aimed at improving
the treatment of type 1 diabetes by developing novel insulin delivery
products to enhance the use of insulin pumps (JDRF) |
| |
|
|
Diabetes
is associated with impaired myocardial performance in patients
without significant coronary artery disease |
| |
In patients without significant CAD, DM is associated
with an impaired systolic longitudinal LV function and global diastolic
dysfunction. These abnormalities are likely to be markers of adverse
prognosis (Cardio Vascular Diabetology) |
| |
|
|
Peripheral
arterial disease in diabetes—a review |
| |
Measurement of ankle-brachial pressure index
(ABI) has emerged as the relatively simple, non-invasive and inexpensive
diagnostic tool of choice ... Efforts towards increasing awareness
and intensive treatment of the risk factors will help to reduce
morbidity and mortality in diabetic patients with PAD (Diabetic
Medicine) |
| |
|
|
Prevention
and treatment of microvascular disease in childhood type 1 diabetes |
| |
There is growing interest in the development
of new preventive and therapeutic strategies targeting specific
pathways implicated in the pathogenesis of microvascular complications
(British Medical Bulletin) |
| |
|
|
Novo
Nordisk Gains Approval for Type 2 Diabetes Treatment in Japan |
| |
Novo Nordisk received Japanese regulatory clearance
for the type 2 diabetes therapy Victoza® (liraglutide). The drug is indicated as either a monotherapy or along with sylphonylurea.
Launch in Japan is expected during the first half of 2010 upon
completion of price negotiations (GEN) |
| |
|
|
Takeda
wins Japanese approval for diabetes drug |
| |
Unlike normal tablets, Actos OD tablets disintegrate
into the oral cavity and can be taken easily without water, which
is expected to improve patient dosing compliance and promote better
glycemic control (Trading Markets) |
| |
|
|
Diabetes:
Magnitude and Mechanisms |
| |
During the next 2 years, Clinical Diabetes will
devote space in each issue to reviewing the fundamentals of diabetes
care for physicians in training (Clinical Diabetes) |
| |
|
|
Hemoglobin
glycation index: a robust measure of hemoglobin A1c bias in pediatric
type 1 diabetes patients |
| |
Biological variation in A1c is a robust quantitative
trait that can be assessed using HGI calculated from routine clinic
data. This suggests that HGI could be used clinically for more
personalized assessment of complications risk (Pediatric Diabetes) |
| |
|
|
Inhaled
insulin: overview of a novel route of insulin administration |
| |
This review will discuss pulmonary delivery
of insulin via inhalation. The safety of inhaled insulin as well
as the efficacy in comparison to subcutaneous insulin in the various
populations with diabetes are covered (Vascular Health and Risk
Management) |
| |
|
|
Buccal
Alterations in Diabetes Mellitus |
| |
Pathophysilology, prevention and treatment (Diabetology & Metabolic
Syndrome) |
| |
|
|
Diabetes
gene points way to new treatments |
| |
Scientists from 174 research centres around
the world, who studied the genes and blood glucose level of more
than 120,000 volunteers, were able to identify a set of genes that
control the body’s response to glucose in the blood (Times, UK) |
| |
|
|
Predicted
annual costs for inpatients with diabetes and foot ulcers in
a developing country—a simulation of the current situation in Brazil |
| |
Our model shows that the social and economic
impact of diabetic foot disease in Brazil is high. Government decision
makers should reflect on the current situation and provide organized
foot care throughout the whole country (Diabetic Medicine) |
| |
|
|
New
sensor could help treat, combat diabetes, other diseases |
| |
University of Florida engineers have designed
and tested versions of the sensor for applications ranging from
monitoring diabetics' glucose levels via their breath to detecting
possible indicators of breast cancer in saliva (GEN) |
| |
|
